Patent ID: 6800659
Filing Date: 2004-10-05
Classification: A61P,C07C,C07F,Y02P

Abstract:
A pharmaceutical composition comprising a compound selected from:(E,E)-2-(benzylaminocarbonyl)-3-(3,4-dihydroxystyryl)acrylontrile (CR4); (E,E)-2-(3,4-dihydroxybenzylaminocarbonyl)-3-(3,5-dimethoxy-4-hydroxystyryl)acrylonitrile (CR11); (E,E)-2-aminocarbonyl-3-(3,4-dihydroxystyryl)acrylonitrile (CR17); (E,E)-2-(3,4-dihydroxybenzylaminocarbonyl)-3-styrylacrylonitrile (CR19); (E,E)-2-(3,4-dihydroxybenzylaminocarbonyl)-3-(3,4-dihydroxystyryl)acrylonitrile (CR21); and (E,E)-2-(&bgr;-ethanolaminocarbonyl)-3-(3,5-dimethoxy-4-hydroxystyryl)acrylonitrile (CR24).